BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 26898552)

  • 1. The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer's Disease.
    Hays CC; Zlatar ZZ; Wierenga CE
    Cell Mol Neurobiol; 2016 Mar; 36(2):167-79. PubMed ID: 26898552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer's disease.
    Wierenga CE; Hays CC; Zlatar ZZ
    J Alzheimers Dis; 2014; 42 Suppl 4(Suppl 4):S411-9. PubMed ID: 25159672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal Cerebral Blood Flow Changes in Normal Aging and the Alzheimer's Disease Continuum Identified by Arterial Spin Labeling MRI.
    Camargo A; Wang Z;
    J Alzheimers Dis; 2021; 81(4):1727-1735. PubMed ID: 33967053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral blood flow measured by arterial spin labeling MRI at resting state in normal aging and Alzheimer's disease.
    Zhang N; Gordon ML; Goldberg TE
    Neurosci Biobehav Rev; 2017 Jan; 72():168-175. PubMed ID: 27908711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assessment of cerebral hemodynamic parameters by QUASAR arterial spin labeling in Alzheimer's disease and cognitively normal Elderly adults at 3-tesla.
    Mak HK; Chan Q; Zhang Z; Petersen ET; Qiu D; Zhang L; Yau KK; Chu LW; Golay X
    J Alzheimers Dis; 2012; 31(1):33-44. PubMed ID: 22504315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral perfusion in the predementia stages of Alzheimer's disease.
    Binnewijzend MA; Benedictus MR; Kuijer JP; van der Flier WM; Teunissen CE; Prins ND; Wattjes MP; van Berckel BN; Scheltens P; Barkhof F
    Eur Radiol; 2016 Feb; 26(2):506-14. PubMed ID: 26040647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Vascular Hypothesis of Alzheimer's Disease: A Key to Preclinical Prediction of Dementia Using Neuroimaging.
    de la Torre J
    J Alzheimers Dis; 2018; 63(1):35-52. PubMed ID: 29614675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age‑ and brain region‑associated alterations of cerebral blood flow in early Alzheimer's disease assessed in AβPPSWE/PS1ΔE9 transgenic mice using arterial spin labeling.
    Guo Y; Li X; Zhang M; Chen N; Wu S; Lei J; Wang Z; Wang R; Wang J; Liu H
    Mol Med Rep; 2019 Apr; 19(4):3045-3052. PubMed ID: 30816468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal gradient during famous face naming is associated with lower cerebral blood flow and gray matter volume in aging.
    Hays CC; Zlatar ZZ; Campbell L; Meloy MJ; Wierenga CE
    Neuropsychologia; 2017 Dec; 107():76-83. PubMed ID: 29133109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative Study of the Changes in Cerebral Blood Flow and Iron Deposition During Progression of Alzheimer's Disease.
    Li D; Liu Y; Zeng X; Xiong Z; Yao Y; Liang D; Qu H; Xiang H; Yang Z; Nie L; Wu PY; Wang R
    J Alzheimers Dis; 2020; 78(1):439-452. PubMed ID: 32986675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid and tau pathology are associated with cerebral blood flow in a mixed sample of nondemented older adults with and without vascular risk factors for Alzheimer's disease.
    Swinford CG; Risacher SL; Vosmeier A; Deardorff R; Chumin EJ; Dzemidzic M; Wu YC; Gao S; McDonald BC; Yoder KK; Unverzagt FW; Wang S; Farlow MR; Brosch JR; Clark DG; Apostolova LG; Sims J; Wang DJ; Saykin AJ
    Neurobiol Aging; 2023 Oct; 130():103-113. PubMed ID: 37499587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity.
    Binnewijzend MA; Kuijer JP; Benedictus MR; van der Flier WM; Wink AM; Wattjes MP; van Berckel BN; Scheltens P; Barkhof F
    Radiology; 2013 Apr; 267(1):221-30. PubMed ID: 23238159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The identification and cognitive correlation of perfusion patterns measured with arterial spin labeling MRI in Alzheimer's disease.
    Meng M; Liu F; Ma Y; Qin W; Guo L; Peng S; Gordon ML; Wang Y; Zhang N
    Alzheimers Res Ther; 2023 Apr; 15(1):75. PubMed ID: 37038198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of MRI hippocampal volumetry and arterial spin labeling MR perfusion at 3-Tesla improves the efficacy in discriminating Alzheimer's disease from cognitively normal elderly adults.
    Mak HK; Qian W; Ng KS; Chan Q; Song YQ; Chu LW; Yau KK
    J Alzheimers Dis; 2014; 41(3):749-58. PubMed ID: 24670395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral blood flow is diminished in asymptomatic middle-aged adults with maternal history of Alzheimer's disease.
    Okonkwo OC; Xu G; Oh JM; Dowling NM; Carlsson CM; Gallagher CL; Birdsill AC; Palotti M; Wharton W; Hermann BP; LaRue A; Bendlin BB; Rowley HA; Asthana S; Sager MA; Johnson SC
    Cereb Cortex; 2014 Apr; 24(4):978-88. PubMed ID: 23236200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of functional hyperemia to visual stimulation in mild Alzheimer's disease and its sensitivity to cholinesterase inhibition.
    Janik R; Thomason LA; Chaudhary S; Dorr A; Scouten A; Schwindt G; Masellis M; Stanisz GJ; Black SE; Stefanovic B
    Biochim Biophys Acta; 2016 May; 1862(5):957-65. PubMed ID: 26521151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvascular perfusion based on arterial spin labeled perfusion MRI as a measure of vascular risk in Alzheimer's disease.
    Zhang Q; Stafford RB; Wang Z; Arnold SE; Wolk DA; Detre JA
    J Alzheimers Dis; 2012; 32(3):677-87. PubMed ID: 22886015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral Blood Flow Is Associated with Diagnostic Class and Cognitive Decline in Alzheimer's Disease.
    Duan W; Sehrawat P; Balachandrasekaran A; Bhumkar AB; Boraste PB; Becker JT; Kuller LH; Lopez OL; Gach HM; Dai W
    J Alzheimers Dis; 2020; 76(3):1103-1120. PubMed ID: 32597803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower cerebral blood flow is associated with impairment in multiple cognitive domains in Alzheimer's disease.
    Leeuwis AE; Benedictus MR; Kuijer JPA; Binnewijzend MAA; Hooghiemstra AM; Verfaillie SCJ; Koene T; Scheltens P; Barkhof F; Prins ND; van der Flier WM
    Alzheimers Dement; 2017 May; 13(5):531-540. PubMed ID: 27693109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.